The Cancer Center at NIT is a Basic Cancer Center comprising three integrated research programs involving more than two dozen laboratories at NIT. Most laboratories are located in three buildings of the Biology Department (Cancer Center, Biology building, Whitehead Institute) and share many common research facilities. Research programs focus on the underlying cell and molecular biology of cell behavior with particular emphasis on issues related to cancer; control of cell proliferation, cell cycle and cell survival, gene expression, cell adhesion and migration, tumor progression, angiogenesis and metastasis. There is a strong emphasis on the use of genetics and molecular genetics to discover genes controlling these processes and/or altered in cancer using human genomics and genetic studies in model organisms (mice, zebrafish, invertebrates and yeast). Three programs in Molecular Genetics & Immunology, Tumor Suppressors, Cell Cycle & Checkpoints, and Cell Biology, Development & Differentiation unite the center members; each is headed by a leader in the field. The major budget requests are to fund shared facilities (Biopolymers, Cell Sorter, Computing Glassware, Histology, Media Preparation, Microarray Technologies, Microscopy, Monoclonal Antibodies, Shared Research Resources, Transgenic Mouse Facility) and infrastructure that support and enhance the scientific research of the center and for developmental funds to foster new directions and initiatives in cancer research. No funds are requested for senior leadership or staff investigator salaries.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014051-30
Application #
6375566
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1975-09-01
Project End
2005-04-30
Budget Start
2001-06-01
Budget End
2002-04-30
Support Year
30
Fiscal Year
2001
Total Cost
$1,670,013
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Clancy-Thompson, Eleanor; Devlin, Christine A; Tyler, Paul M et al. (2018) Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses. Cancer Immunol Res 6:1524-1536
Fiedler, Eleanor R C; Bhutkar, Arjun; Lawler, Emily et al. (2018) In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL. Blood Adv 2:1229-1242
Sullivan, Lucas B; Luengo, Alba; Danai, Laura V et al. (2018) Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol 20:782-788
Miller, Eric A; Baniya, Subha; Osorio, Daniel et al. (2018) Paper-based diagnostics in the antigen-depletion regime: High-density immobilization of rcSso7d-cellulose-binding domain fusion proteins for efficient target capture. Biosens Bioelectron 102:456-463
Lannagan, Tamsin R M; Lee, Young K; Wang, Tongtong et al. (2018) Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut :
Filbin, Mariella G; Tirosh, Itay; Hovestadt, Volker et al. (2018) Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science 360:331-335
Roper, Jatin; Tammela, Tuomas; Akkad, Adam et al. (2018) Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation. Nat Protoc 13:217-234
Suzuki, Hiroshi I; Spengler, Ryan M; Grigelioniene, Giedre et al. (2018) Deconvolution of seed and RNA-binding protein crosstalk in RNAi-based functional genomics. Nat Genet 50:657-661
McKenney, Anna Sophia; Lau, Allison N; Somasundara, Amritha Varshini Hanasoge et al. (2018) JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. J Clin Invest 128:789-804
Richardson, Christopher E R; Cunden, Lisa S; Butty, Vincent L et al. (2018) A Method for Selective Depletion of Zn(II) Ions from Complex Biological Media and Evaluation of Cellular Consequences of Zn(II) Deficiency. J Am Chem Soc 140:2413-2416

Showing the most recent 10 out of 904 publications